Literature DB >> 1572232

Pleural diseases.

R W Light1.   

Abstract

In the United States, approximately one million patients each year develop a pleural effusion. Pleural effusions have classically been divided into transudative and exudative pleural effusions. A transudative pleural effusion occurs when the systemic factors influencing pleural fluid formation and reabsorption are altered so that pleural fluid accumulates; an exudative pleural effusion occurs when the local factors influencing pleural fluid formation and reabsorption are altered, allowing accumulation of pleural fluid. The leading causes of transudative pleural effusions are left ventricular failure and cirrhosis with ascites. The leading causes of exudative pleural effusions are pneumonia, malignancy, and pulmonary embolization. Transudative pleural effusions can be differentiated from exudative pleural effusions by measurement of the pleural fluid protein and lactic dehydrogenase (LDH) levels. The ratio of the pleural fluid protein to the serum protein is less than 0.5, the ratio of the pleural fluid LDH to the serum LDH is less than 0.6, and the absolute value of the pleural fluid LDH level is less than two thirds of the upper normal limit for serum with transudative pleural effusions while at least one of these criteria is not met with exudative effusions. Most patients who have a pleural effusion with congestive heart failure have left ventricular failure. It is believed that the transudation of the pulmonary interstitial fluid across the visceral pleura overwhelms the capacity of the lymphatics to remove the fluid. Most patients with cirrhosis who have a pleural effusion also have ascites. It is also believed that the pleural effusions form when fluid moves directly from the peritoneal cavity into the pleural cavity through pores in the diaphragm. Approximately 40% of patients with pneumonia will have a pleural effusion. If these patients have a significant amount of pleural fluid, a diagnostic thoracentesis should be performed. Chest tubes should be inserted if the pleural fluid is gross pus, if the Gram stain of the pleural fluid is positive, if the pleural fluid glucose level is below 40 mg/dl, or if the pleural fluid pH level is less than 7.00. If drainage with the chest tubes is unsatisfactory, either streptokinase or urokinase should be injected intrapleurally. If drainage is still unsatisfactory, a decortication should be considered. The three leading malignancies that have an associated pleural effusion are breast carcinoma, lung carcinoma, lymphomas and leukemias. The diagnosis of pleural malignancy is made most commonly with pleural fluid cytology; in recent years immunohistochemical tests have proved invaluable in differentiating benign from malignant pleural effusions.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1572232     DOI: 10.1016/0011-5029(92)90007-c

Source DB:  PubMed          Journal:  Dis Mon        ISSN: 0011-5029            Impact factor:   3.800


  18 in total

1.  Group A streptococcal meningitis with an infected BCG scar.

Authors:  M Melzer; U Joashi; I Murdoch; W Gransden
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

2.  Rupture of the ankle extensor retinaculum in a dancer.

Authors:  G Tytherleigh-Strong; R Baxandall; A Unwin
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

3.  Acromegaly, primary thyrotoxicosis, a dense left hemiparesis and a right internal carotid aneurysm.

Authors:  R I Holt; J K Powrie; P H Sönksen
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

4.  Malign anterior knee pain.

Authors:  A Boyle; N Walton
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

5.  Haemothorax via an intact diaphragm.

Authors:  M R Clatworthy; P D Edwards; J W Grant; J Monteiro; D K Menon
Journal:  J R Soc Med       Date:  2000-12       Impact factor: 5.344

6.  The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Authors:  John S Bradley; Carrie L Byington; Samir S Shah; Brian Alverson; Edward R Carter; Christopher Harrison; Sheldon L Kaplan; Sharon E Mace; George H McCracken; Matthew R Moore; Shawn D St Peter; Jana A Stockwell; Jack T Swanson
Journal:  Clin Infect Dis       Date:  2011-08-31       Impact factor: 9.079

7.  Secondary infection of chylothorax with Serratia marcescens: a rare scenario post-cardiac surgery.

Authors:  Karthik Kumaran; Sowmya Ramanan; Baiju Sasi Dharan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2019-10-14

8.  Perioperative Considerations for Chylothorax.

Authors:  Joseph Morabito; Marshall T Bell; Leon J Montenij; Lena M Mayes; Zenggang Pan; Jan M Dieleman; Robert A Meguid; Karsten Bartels
Journal:  J Cardiothorac Vasc Anesth       Date:  2017-06-03       Impact factor: 2.628

9.  Elevated expression of prostaglandin receptor and increased release of prostaglandin E2 maintain the survival of CD45RO+ T cells in the inflamed human pleural space.

Authors:  Elisabetta Pace; Tony F Bruno; Byron Berenger; Christopher H Mody; Mario Melis; Maria Ferraro; Annalisa Tipa; Andreina Bruno; Mirella Profita; Giovanni Bonsignore; Mark Gjomarkaj
Journal:  Immunology       Date:  2007-04-26       Impact factor: 7.397

10.  Medical Thoracoscopy vs Closed Pleural Biopsy in Pleural Effusions: A Randomized Controlled Study.

Authors:  Nithya Haridas; Suraj K P; Rajagopal T P; James P T; Ravindran Chetambath
Journal:  J Clin Diagn Res       Date:  2014-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.